Details for 2014724909

Up to date per 01.04.2026

Actions

Title / Product Name

CABOZANTINIB DOSIERUNGSFORM UND VERWENDUNG ZUR BEHANDLUNG VON KREBS

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2014724909

EP Publication Number

2981263

E-Number

1500833

Language

PCT Number

US14033016

Publication Date

10.02.2016 A

29.06.2022 B1

Registration Date

29.06.2022

AT Publication Date

15.07.2022

Application Date

04.04.2014

Registration Number

Priorities

04.04.2013

201361808511 P

IPC

A61K 9/20 20060101AFI20211125BHEP

Maximum Duration of Protection

04.04.2034

Owner

Exelixis, Inc.1851 Harbor Bay Parkway Alameda, CA 94502US

Representative

No representatives present

Inventor

WEITZMAN, Aaron12195 Altamont Court Los Altos Hills, CA 94022US